Tyrosine kinases as targets for cancer therapy (Q35045444)

6 August 2017

1 reference

title

Tyrosine kinases as targets for cancer therapy. (English)

1 reference

6 August 2017

Alexander Levitzki

1

1 reference

6 August 2017

1 September 2002

1 reference

European Journal of Cancer

6 August 2017

1 reference

6 August 2017

38 Suppl 5

1 reference

6 August 2017

S11-8

1 reference

Tyrphostins--potential antiproliferative agents and novel molecular tools

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Signal-transduction therapy. A novel approach to disease management

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Tyrphostins IV--highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Substrate competitive inhibitors of IGF-1 receptor kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

ROS, stress-activated kinases and stress signaling in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Drug development train gathering steam

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Tyrphostins. II. Heterocyclic and .alpha.-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Tyrphostins. 3. Structure-activity relationship studies of alpha-substituted benzylidenemalononitrile 5-S-aryltyrphostins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Protein tyrosine kinase inhibitors as novel therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Tyrphostins suppress the growth of psoriatic keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2980598-6

7 January 2021

10.1016/S0959-8049(02)80598-6

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12528768